Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop.

Autor: Jarow JP; Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, MD. Electronic address: Jonathan.jarow@fda.hhs.gov., Thompson IM; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX., Kluetz PG; Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Silver Spring, MD., Baxley J; Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD., Sridhara R; Division of Biometrics V, Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD., Scardino P; Department of Surgery, David H. Koch Chair, Memorial Sloan-Kettering Cancer Center, New York, NY., Carroll P; Department of Urology, Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Albertsen P; University of Connecticut Health Center, Farmington, CT., Carter HB; Johns Hopkins School of Medicine, Baltimore, MD., Brawley O; American Cancer Society, Emory University, Atlanta, GA., Sartor O; Laborde Professor for Cancer Research, Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA., Sandler H; Ronald H. Bloom Chair in Cancer Therapeutics, Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA., Kiefert JJ; Board Chairman Emeritus, Us TOO, International, Des Plaines, IL., Morton RA Jr; American Medical Systems, Minnetonka, MN.

Publikováno v: Urology [Urology] 2014 May; Vol. 83 (5), pp. 975-8. Date of Electronic Publication: 2014 Mar 22.

Race is not an independent predictor of positive surgical margins after radical prostatectomy.

Autor: Witte MN; Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA., Kattan MW, Albani J, Sharp DS, Eastham JA, Morton RA Jr

Publikováno v: Urology [Urology] 1999 Nov; Vol. 54 (5), pp. 869-74.

Molecular genetics of prostate cancer: clinical applications.

Autor: Morton RA Jr; Department of Urology, Baylor College of Medicine, Houston, Texas, USA., Isaacs WB

Publikováno v: Journal of the National Medical Association [J Natl Med Assoc] 1998 Nov; Vol. 90 (11 Suppl), pp. S728-31.

Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue.

Autor: Morton RA Jr; James Buchanan Brady Institute of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Watkins JJ, Bova GS, Wales MM, Baylin SB, Isaacs WB

Publikováno v: The Journal of urology [J Urol] 1996 Aug; Vol. 156 (2 Pt 1), pp. 512-6.

Racial differences in adenocarcinoma of the prostate in North American men.

Autor: Morton RA Jr; Scott Department of Urology, Baylor College of Medicine, Houston, Texas.

Publikováno v: Urology [Urology] 1994 Nov; Vol. 44 (5), pp. 637-45.